New Protection Against Oral and Aerosol Ricin Exposure With Its Ricin Vaccine RiVax(TM)

DOR BioPharma Announces Publication Describing Protection Against Oral and Aerosol Ricin Exposure With Its Ricin Vaccine RiVax(TM)

MIAMI, FL -- 09/05/07 -- DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company") announced today results from animal testing of RiVax(TM), its vaccine against ricin toxin, have been published online in the journal Vaccine, Smallshaw et al., "RiVax(TM), A Recombinant Ricin Subunit Vaccine, Protects Mice Against Ricin Given by Gavage or Aerosol"

Article: http://dx.doi.org/doi:10.1016/j.vaccine.2007.08.018